---
title: "合生创展：2025 年 9 月总销售额达 13.62 亿元人民币。"
description: "合生创展：2025 年 9 月总销售额达 13.62 亿元人民币。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/261221178.md"
published_at: "2025-10-15T09:50:27.000Z"
---

# 合生创展：2025 年 9 月总销售额达 13.62 亿元人民币。

合生创展：2025 年 9 月总销售额达 13.62 亿元人民币。

### Related Stocks

- [00754.HK - 合生创展集团](https://longbridge.com/zh-CN/quote/00754.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Will China Literature Turn The Page? | China Literature Ltd. expects a net loss of up to 850 million yuan for last year, primarily due to a 1.8 billion yuan go | [Link](https://longbridge.com/zh-CN/news/276113491.md) |
| Rusta accelerates Nordic expansion with 13 new store openings in spring 2026 | Rusta AB is set to expand its presence in the Nordic region by opening 13 new stores in Sweden, Norway, and Finland in t | [Link](https://longbridge.com/zh-CN/news/276212842.md) |
| 13:47 ETNorthborne Partners Advises FORTA in Connection with its Acquisition by The Heritage Group | Northborne Partners has advised FORTA, a synthetic fiber manufacturer, in its acquisition by The Heritage Group. The fin | [Link](https://longbridge.com/zh-CN/news/276261784.md) |
| Cloud Range Introduces AI Validation Range, Enabling Organizations to Test, Validate, and Secure AI Before Deployment | Cloud Range has launched its AI Validation Range, a virtual platform for organizations to test and validate AI models se | [Link](https://longbridge.com/zh-CN/news/276219422.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-CN/news/276051793.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。